tiprankstipranks
Jacobio to Unveil JAB-8263 Clinical Data at ASH 2024
Company Announcements

Jacobio to Unveil JAB-8263 Clinical Data at ASH 2024

Jacobio Pharmaceuticals Group Co., Ltd. (HK:1167) has released an update.

Don't Miss Our Christmas Offers:

Jacobio Pharmaceuticals Group Co., Ltd. will showcase clinical data for their BET inhibitor, JAB-8263, at the upcoming 66th American Society of Hematology Annual Meeting in December 2024. The company, which is dedicated to creating innovative health solutions across six major signaling pathways, cautions there is no guarantee of JAB-8263’s successful development or marketability.

For further insights into HK:1167 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App